Robert Dreicer, MD, MS, FACP | Authors

ASCO: Preview of the Prostate Cancer Sessions

May 30, 2013

Ahead of the 2013 ASCO meeting we highlight some of this year's prostate cancer sessions, many of which focus on how best to use the new agents that have been approved recently, as well as looking into new drugs and combinations presented from early trials.